HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charis Papavassilis Selected Research

Interleukin-17 (Interleukin 17)

10/2023Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
12/2020Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis.
1/2018Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies.
10/2016Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE Trial.
4/2016Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.
12/2014Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study.
7/2014Secukinumab in plaque psoriasis--results of two phase 3 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charis Papavassilis Research Topics

Disease

16Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 09/2013
2Infections
07/2016 - 07/2014
1Nasopharyngitis
10/2016
1Candidiasis (Moniliasis)
07/2016
1Neoplasms (Cancer)
07/2016
1Pruritus (Itching)
04/2016
1Pain (Aches)
04/2016
1Psoriatic Arthritis
08/2015

Drug/Important Bio-Agent (IBA)

14secukinumabIBA
10/2023 - 09/2013
8Monoclonal AntibodiesIBA
10/2023 - 07/2014
7Interleukin-17 (Interleukin 17)IBA
10/2023 - 07/2014
4Immunoglobulin A (IgA)IBA
10/2016 - 12/2014
3Etanercept (Enbrel)FDA Link
07/2016 - 07/2014
2CytokinesIBA
12/2020 - 12/2014
1Biomarkers (Surrogate Marker)IBA
12/2020
1Prostaglandins AIBA
02/2015

Therapy/Procedure

2Biological Therapy
01/2018 - 09/2017
2Therapeutics
08/2017 - 04/2016
1Self Administration (Administration, Self)
10/2016
1Phototherapy (Light Therapy)
04/2016
1Retreatment
07/2015